Illustration credit: Amanda Northrop
As 23andMe struggles, another genetic testing company bets on drug discovery
Two years ago, GeneDx was teetering. The genetic testing company had laid off 33% of its staff, shares were down 90% from a year prior …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
